CpG-ODN have been demonstrated to stimulate IL-10-producing B cells and have shown the capacity to prevent and reverse allergic immune reactions in several animal models, indicating their potential as a preventive and active treatment for allergic disease. This evidence concerns the gene IL10 and allergic disease.